Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-011612
Filing Date
2023-10-24
Accepted
2023-10-24 10:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27541
2 filename2.txt TEXT-EXTRACT 1234
  Complete submission text file 0000000000-23-011612.txt   39966
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filed for) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations